Efficacy of Donepezil in the posterior variant of Alzheimers disease (Posterior Cortical Atrophy) Study

Trial Profile

Efficacy of Donepezil in the posterior variant of Alzheimers disease (Posterior Cortical Atrophy) Study

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms DONIPAD
  • Most Recent Events

    • 20 Jul 2017 Primary endpoint (Performance on the Mini Mental State Examination (MMSE) at 12 weeks) has not been met, according to results presented at the Alzheimer's Association International Conference 2017.
    • 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017.
    • 05 Jan 2012 Status changed from active, no longer recruiting to completed as reported by UKCRN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top